Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Otonomy Inc (OTIC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Otonomy Inc 4796 EXECUTIVE DRIVE SAN DIEGO CA 92121 USA

P: 619-323-2200

Description:

Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It develops therapeutics for treatment of inner and middle ear disorders. The Company's product candidates under development includes AuriPro to treat pediatric patients with middle ear effusion; and OTO-104 for the treatment of patients with M'ni're's disease. Otonomy, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 86,225
Shares Outstanding, K 30,685
Annual Sales, $ 750 K
Annual Net Income, $ -50,370 K
Last Quarter Sales, $ 190 K
Last Quarter Net Income, $ -11,980 K
60-Month Beta 2.51
% of Insider Shareholders 11.70%
% of Institutional Shareholders 57.65%
Float, K 27,095
% Float 88.30%

Growth:

1-Year Return -43.79%
3-Year Return -81.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 62.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/06/19
Earnings Per Share ttm -1.66
EPS Growth vs. Prev Qtr 7.14%
EPS Growth vs. Prev Year -5.41%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

OTIC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.53
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -60.14
Return-on-Assets (Before Tax) -48.08
Profit Margin % -6,716.00
Net Margin % N/A
Debt/Equity 0.19
Price/Sales 116.56
Price/Cash Flow N/A
Price/Book 1.25
Book Value/Share 2.26
Interest Coverage -29.65
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar